Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-02-26 @ 11:16 AM
Study NCT ID:
NCT02916251
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2016-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
Sponsor:
Zealand Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-05
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-08
First Submit QC Date:
None
Study First Post Date:
2016-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-20
Last Update Post Date:
2017-04-21
Last Update Post Date Type:
ACTUAL